Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Journal of Antivirals & Antiretrovirals : Citations & Metrics Report

Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.

Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

59 57 32 59 77 13 11 20 37 22 37 55 22 12

Research, Review articles and Editorials

1 0 5 42 32 12 10 14 27 21 33 44 21 10

Research communications, Review communications, Editorial communications, Case reports and Commentary

48 57 27 17 45 1 1 6 10 1 4 11 1 2

Conference proceedings

0 0 0 0 0 0 35 51 125 100 191 0 125 177

Citations received as per Google Scholar, other indexing platforms and portals

98 160 172 269 223 172 219 195 170 116 60 36 26 58
Journal total citations count 2004
Journal impact factor 5.32
Journal 5 years impact factor 5.62
Journal cite score 5.3
Journal h-index 22
Journal h-index since 2019 17
Important citations (1101)

shang h, zhang l (2015) msm and hiv-1 infection in china. national science review 2: 388-391.

yan h, ding y, wong fy, ning z, zheng t, et al. (2015) epidemiological and molecular characteristics of hiv infection among money boys and general men who have sex with men in shanghai, china. infection, genetics and evolution 31: 135-141.

wang x, wu y, mao l, xia w, zhang w, et al. (2015) targeting hiv prevention based on molecular epidemiology among deeply sampled subnetworks of men who have sex with men. clinical infectious diseases 61: 1462-1468.

rehman au, ali f, ali m, alam i, khan aw (2016) changes in hematological parameters with pegylated interferon in chronic hepatitis c virus infected patients. asian pacific journal of cancer prevention 17: 2485-2490.

mateos-muñoz b, larrad-sáinz a, torrejón ml, devesa-medina mj, matía-martín mp, et al. (2016) the relation of fibrosis stage with nutritional deficiencies and bioelectrical impedance analysis of body composition in patients with chronic hepatitis c. ann hepatol 1.

santos pr, formagio as, nakamura cv, sarragiotto mh, ueda-nakamura t (2015) effect of 1-(phenyl)-n’-(4-methoxybenzylidene)-9h-pyrido [3, 4-b] indole-3-carbohydrazide on in vitro poliovirus replication. acta pharmaceutica 65: 75-81.

earla p (2014) ancient diseases-microbial impact. journal of ancient diseases & preventive remedies.

sharma s, chatterjee s, datta s, prasad r, dubey d, et al. (2017) bacteriophages and its applications: an overview. folia microbiologica 62: 17-55.

mathew s (2016) a need for careful consideration of bacteriophage therapy. indian journal of medical research 144: 482.

saraswathi r, prabhusaran n, sherin beatrice r, velayutharaj a, uma a. in vitro evaluation of bacteriophages against bacterial pathogens from wound infections.

oduor jm. evaluation of safety and therapeutic potential of environmental waste water lytic bacteriophage against multidrug resistant staphylococcus aureus (mdrsa) in balb/c mice (doctoral dissertation, kenyatta university).

holguín av, rangel g, clavijo v, prada c, mantilla m, et al. (2015) a putative temperate phage, controls pseudomonas aeruginosa in planktonic, biofilm and burn mouse model assays. viruses 7: 4602-4623.

dorotkiewicz-jach a, augustyniak d, olszak t, drulis-kawa z (2015) modern therapeutic approaches against pseudomonas aeruginosa infections. current medicinal chemistry 22: 1642-1664.

singh g, pai rs, mustafa s (2015) nanostructured delivery systems: augmenting the delivery of antiretroviral drugs for better management of hiv/aids. critical reviews™ in therapeutic drug carrier systems 32.

singh j, desai s, yadav s, narasimhan b, kaur h (2016) polymer drug conjugates: recent advancements in various diseases. current pharmaceutical design. 22: 2821-2843.

aderibigbe ba. design and therapeutic efficacy of polymer based drug delivery systems for antimalarials.

chander sharma p, piplani m, mittal m, pahwa r (2016) insight into prodrugs of quinolones and fluoroquinolones. infectious disorders-drug targets (formerly current drug targets-infectious disorders) 16: 140-161.

aderibigbe ba (2015) polymeric prodrugs containing metal-based anticancer drugs. journal of inorganic and organometallic polymers and materials. 25: 339-353.

singh j, desai s, yadav s, narasimhan b, kaur h (2016) polymer drug conjugates: recent advancements in various diseases. current pharmaceutical design 22: 2821-2843.

paramjot, khan nm, kapahi h, kumar s, bhardwaj tr, et al. (2015) role of polymer–drug conjugates in organ-specific delivery systems. journal of drug targeting 23: 387-416.

Top